All Stories

  1. Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in Iceland: The treatment as prevention for Hepatitis C (TraP HepC) study

    Article • International Journal of Drug Policy, November 2024, Elsevier

    Thorvardur Love

  2. Population-based screening cohort study reveals no association between monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), multiple myeloma (MM), and alopecia

    Article • Archives of Dermatological Research, September 2024, Springer Science + Business Media

    Thorvardur Love

  3. Comparing DAPSA, DAPSA28, and DAS28‐CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries

    Article • Arthritis Care & Research, August 2024, Wiley

    Thorvardur Love

  4. Deciphering the genetics and mechanisms of predisposition to multiple myeloma

    Article • Nature Communications, August 2024, Springer Science + Business Media

    Dr. Malte Thodberg, Dr. Hauke Thomsen, Thorvardur Love

  5. Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment

    Article • Joint Bone Spine, July 2024, Elsevier

    Thorvardur Love

  6. Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance

    Article • Annals of Internal Medicine, June 2024, American College of Physicians

    Thorvardur Love

  7. Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapy: results from the ICEBIO registry

    Article • Scandinavian Journal of Rheumatology, June 2024, Taylor & Francis

    Thorvardur Love

  8. Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance

    Article • Annals of Internal Medicine, April 2024, American College of Physicians

    Thorvardur Love

  9. Sex Differences in the Effectiveness of First‐Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network

    Article • Arthritis & Rheumatology, February 2024, Wiley

    Thorvardur Love

  10. Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care

    Article • The Journal of Rheumatology, January 2024, The Journal of Rheumatology

    Thorvardur Love

  11. Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden

    Article • Haematologica, January 2024, Ferrata Storti Foundation (Haematologica)

    Thorvardur Love

  12. Trends of perceived disruption in healthcare services during the pandemic: findings from the COVID-19 National Resilience Cohort in Iceland

    Article • European Journal of Public Health, December 2023, Oxford University Press (OUP)

    Thorvardur Love

  13. Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study

    Article • Blood Cancer Journal, December 2023, Springer Science + Business Media

    Thorvardur Love

  14. Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index

    Article • Blood Cancer Journal, December 2023, Springer Science + Business Media

    Thorvardur Love

  15. Long COVID in Icelandic Children: A Matched Cohort Study of Nonspecific Symptoms Following SARS-CoV-2 Infection

    Article • The Pediatric Infectious Disease Journal, November 2023, Wolters Kluwer Health

    Thorvardur Love

  16. Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration

    Article • Arthritis Research & Therapy, October 2023, Springer Science + Business Media

    Thorvardur Love

  17. Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study

    Article • Haematologica, July 2023, Ferrata Storti Foundation (Haematologica)

    Thorvardur Love

  18. Physical and cognitive impact following SARS-CoV-2 infection in a large population-based case-control study

    Article • Communications Medicine, July 2023, Springer Science + Business Media

    Thorvardur Love

  19. Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries

    Article • Rheumatology, June 2023, Oxford University Press (OUP)

    Professor Merih Birlik, Thorvardur Love

  20. Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

    Article • Annals of the Rheumatic Diseases, June 2023, Elsevier

    Thorvardur Love

  21. Prevalence of smoldering multiple myeloma based on nationwide screening

    Article • Nature Reports Stem Cells, February 2023, Springer Science + Business Media

    Thorvardur Love

  22. Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study

    Article • RMD Open, December 2022, BMJ

    Benedicte Delcoigne, Thorvardur Love

  23. Management of Nail Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

    Article • The Journal of Rheumatology, November 2022, The Journal of Rheumatology

    Thorvardur Love

  24. Comment on: Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogen: reply

    Article • Rheumatology, September 2022, Oxford University Press (OUP)

    Thorvardur Love

  25. Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study

    Article • Blood Cancer Journal, September 2022, Springer Science + Business Media

    Thorvardur Love

  26. SARS-CoV-2 Infections in Icelandic Children: Close Follow-up of All Confirmed Cases in a Nationwide Study

    Article • The Pediatric Infectious Disease Journal, July 2022, Wolters Kluwer Health

    Thorvardur Love

  27. Real‐World Six‐ and Twelve‐Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

    Article • Arthritis Care & Research, April 2022, Wiley

    Thorvardur Love

  28. Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance

    Article • Frontiers in Immunology, April 2022, Frontiers

    Thorvardur Love

  29. Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogen

    Article • Rheumatology, April 2022, Oxford University Press (OUP)

    Thorvardur Love

  30. High Rate of Hepatitis C Virus Reinfection Among Recently Injecting Drug Users: Results From the TraP Hep C Program—A Prospective Nationwide, Population-Based Study

    Article • Clinical Infectious Diseases, April 2022, Oxford University Press (OUP)

    Thorvardur Love

  31. Symptoms, physical measures and cognitive tests after SARS-CoV-2 infection in a large population-based case-control study

    Article • April 2022, Springer Science + Business Media

    Thorvardur Love

  32. Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting

    Article • The Journal of Rheumatology, April 2022, The Journal of Rheumatology

    Thorvardur Love

  33. The first wave of COVID‐19 and concurrent social restrictions were not associated with a negative impact on mental health and psychiatric well‐being

    Article • Journal of Internal Medicine, February 2022, Wiley

    Thorvardur Love

  34. A Patients' Perspective Towards the Injection Devices for Humira® and Imraldi® in a Nationwide Switching Program

    Article • Frontiers in Medicine, January 2022, Frontiers

    Thorvardur Love

  35. Does biologic therapy impact the development of PsA among patients with psoriasis?

    Article • Annals of the Rheumatic Diseases, January 2022, Elsevier

    Thorvardur Love

  36. Validity of chronic disease diagnoses in Icelandic healthcare registries

    Article • Scandinavian Journal of Public Health, December 2021, SAGE Publications

    Thorvardur Love

  37. Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study

    Article • Blood Cancer Journal, December 2021, Springer Science + Business Media

    Thorvardur Love

  38. Outpatient Use of Antimicrobials in Patients With Rheumatoid Arthritis Before and After Treatment With Tumor Necrosis Factor Inhibitors: A Nationwide Retrospective Cohort Study

    Article • ACR Open Rheumatology, November 2021, Wiley

    Thorvardur Love

  39. Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study

    Article • Rheumatology, September 2021, Oxford University Press (OUP)

    Thorvardur Love

  40. Risk Factors for Diagnosis of Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis, and Ankylosing Spondylitis: A Set of Parallel Case-control Studies

    Article • The Journal of Rheumatology, August 2021, The Journal of Rheumatology

    Thorvardur Love

  41. Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study

    Article • The Lancet Gastroenterology & Hepatology, August 2021, Elsevier

    Thorvardur Love

  42. No One Will be Safe Until Our Children are Safe: Parent’s Attitude Towards COVID-19 Childhood Immunization

    Article • The Pediatric Infectious Disease Journal, July 2021, Wolters Kluwer Health

    Thorvardur Love

  43. Illness severity and risk of mental morbidities among patients recovering from COVID-19: a cross-sectional study in the Icelandic population

    Article • BMJ Open, July 2021, BMJ

    Thorvardur Love

  44. Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

    Article • Annals of the Rheumatic Diseases, June 2021, BMJ

    Benedicte Delcoigne, Thorvardur Love

  45. Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies

    Article • Blood Cancer Journal, May 2021, Springer Science + Business Media

    Thorvardur Love

  46. Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland

    Article • Annals of the Rheumatic Diseases, May 2021, Elsevier

    Thorvardur Love

  47. Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting

    Article • The Journal of Rheumatology, February 2021, The Journal of Rheumatology

    Thorvardur Love

  48. Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors – a Nordic cohort study

    Article • Rheumatology, January 2021, Oxford University Press (OUP)

    Benedicte Delcoigne, Thorvardur Love

  49. Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance

    Article • European Journal Of Haematology, December 2020, Wiley

    Thorvardur Love

  50. Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

    Article • Rheumatology, December 2020, Oxford University Press (OUP)

    Thorvardur Love

  51. Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study

    Article • Rheumatology, June 2020, Oxford University Press (OUP)

    Thorvardur Love

  52. FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease

    Article • Nature, June 2020, Springer Science + Business Media

    Thorvardur Love

  53. Impact of discordance between patient’s and evaluator’s global assessment on treatment outcomes in 14 868 patients with spondyloarthritis

    Article • Rheumatology, January 2020, Oxford University Press (OUP)

    Thorvardur Love

  54. Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment—results from 12 countries in EuroSpA

    Article • Rheumatology, October 2019, Oxford University Press (OUP)

    Thorvardur Love

  55. Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible

    Article • RMD Open, July 2019, BMJ

    Thorvardur Love

  56. Golimumab in the treatment of psoriatic arthritis

    Article • Expert Review of Clinical Immunology, September 2018, Taylor & Francis

    Thorvardur Love

  57. Treatment as Prevention for Hepatitis C (TraP Hep C) – a nationwide elimination programme in Iceland using direct‐acting antiviral agents

    Article • Journal of Internal Medicine, March 2018, Wiley

    Thorvardur Love

  58. Infections and the risk of psoriatic arthritis among psoriasis patients: a systematic review

    Article • Rheumatology International, November 2017, Springer Science + Business Media

    Thorvardur Love

  59. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study

    Article • European Heart Journal, April 2017, Oxford University Press (OUP)

    Thorvardur Love

  60. Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis

    Article • Rheumatology, January 2017, Oxford University Press (OUP)

    Thorvardur Love

  61. The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study

    Article • Annals of the Rheumatic Diseases, January 2017, BMJ

    Thorvardur Love

  62. Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland

    Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

    Thorvardur Love

  63. The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries

    Article • Rheumatology, September 2016, Oxford University Press (OUP)

    Thorvardur Love

  64. Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis

    Article • Annals of the Rheumatic Diseases, July 2016, BMJ

    Thorvardur Love

  65. Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study

    Article • Annals of Hematology, March 2016, Springer Science + Business Media

    Thorvardur Love

  66. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Article • Arthritis & Rheumatology, March 2016, Wiley

    Thorvardur Love

  67. Treatments for Nail Psoriasis: A Systematic Review by the GRAPPA Nail Psoriasis Work Group

    Article • The Journal of Rheumatology, November 2014, The Journal of Rheumatology

    Thorvardur Love

  68. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study

    Article • Annals of the Rheumatic Diseases, October 2014, BMJ

    Thorvardur Love

  69. Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network

    Article • Pharmacoepidemiology and Drug Safety, July 2014, Wiley

    Thorvardur Love

  70. Risk for Cardiovascular Disease Early and Late After a Diagnosis of Giant-Cell Arteritis

    Article • Annals of Internal Medicine, January 2014, American College of Physicians

    Thorvardur Love

  71. Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study

    Article • Rheumatology, October 2013, Oxford University Press (OUP)

    Thorvardur Love

  72. Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study

    Article • Annals of the Rheumatic Diseases, December 2012, BMJ

    Thorvardur Love

  73. Prevalence and treatment patterns of psoriatic arthritis in the UK

    Article • Rheumatology, December 2012, Oxford University Press (OUP)

    Thorvardur Love

  74. Psoriatic Arthritis and Onycholysis — Results from the Cross-sectional Reykjavik Psoriatic Arthritis Study

    Article • The Journal of Rheumatology, May 2012, The Journal of Rheumatology

    Thorvardur Love

  75. Obesity and the risk of psoriatic arthritis: a population-based study

    Article • Annals of the Rheumatic Diseases, May 2012, BMJ

    Thorvardur Love

  76. Re: Risk of malignancy associated with Lyme disease: Still up in the air

    Article • International Journal of Cancer, April 2012, Wiley

    Thorvardur Love

  77. Borrelia and subsequent risk of solid tumors and hematologic malignancies in Sweden

    Article • International Journal of Cancer, March 2012, Wiley

    Thorvardur Love

  78. Prevalence of the Metabolic Syndrome in Psoriasis

    Article • Archives of Dermatology, April 2011, American Medical Association (AMA)

    Thorvardur Love

  79. Validation of Psoriatic Arthritis Diagnoses in Electronic Medical Records Using Natural Language Processing

    Article • Seminars in Arthritis and Rheumatism, April 2011, Elsevier

    Thorvardur Love

  80. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis

    Article • Annals of the Rheumatic Diseases, June 2010, BMJ

    Thorvardur Love

  81. Small joint involvement in psoriatic arthritis is associated with onycholysis: the Reykjavik Psoriatic Arthritis Study

    Article • Scandinavian Journal of Rheumatology, May 2010, Taylor & Francis

    Thorvardur Love

  82. A strong heritability of psoriatic arthritis over four generations--the Reykjavik Psoriatic Arthritis Study

    Article • Rheumatology, September 2009, Oxford University Press (OUP)

    Thorvardur Love

  83. A ‘pilot’ study on air-travel and venous thromboembolism

    Article • British Journal of Haematology, August 2009, Wiley

    Thorvardur Love

  84. The relationship between cancer and rheumatoid arthritis: still a large research agenda

    Article • Arthritis Research & Therapy, January 2008, Springer Science + Business Media

    Thorvardur Love

  85. Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8+ T cells

    Article • Clinical & Experimental Immunology, October 2004, Wiley

    Thorvardur Love